1. Home
  2. ELVN vs JBSS Comparison

ELVN vs JBSS Comparison

Compare ELVN & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • JBSS
  • Stock Information
  • Founded
  • ELVN 2016
  • JBSS 1959
  • Country
  • ELVN United States
  • JBSS United States
  • Employees
  • ELVN N/A
  • JBSS N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • JBSS Specialty Foods
  • Sector
  • ELVN Health Care
  • JBSS Consumer Staples
  • Exchange
  • ELVN Nasdaq
  • JBSS Nasdaq
  • Market Cap
  • ELVN 1.2B
  • JBSS 736.2M
  • IPO Year
  • ELVN 2020
  • JBSS 1991
  • Fundamental
  • Price
  • ELVN $21.14
  • JBSS $66.61
  • Analyst Decision
  • ELVN Strong Buy
  • JBSS
  • Analyst Count
  • ELVN 5
  • JBSS 0
  • Target Price
  • ELVN $41.20
  • JBSS N/A
  • AVG Volume (30 Days)
  • ELVN 712.6K
  • JBSS 90.3K
  • Earning Date
  • ELVN 08-12-2025
  • JBSS 08-19-2025
  • Dividend Yield
  • ELVN N/A
  • JBSS 4.68%
  • EPS Growth
  • ELVN N/A
  • JBSS N/A
  • EPS
  • ELVN N/A
  • JBSS 4.72
  • Revenue
  • ELVN N/A
  • JBSS $1,107,742,000.00
  • Revenue This Year
  • ELVN N/A
  • JBSS N/A
  • Revenue Next Year
  • ELVN N/A
  • JBSS N/A
  • P/E Ratio
  • ELVN N/A
  • JBSS $13.85
  • Revenue Growth
  • ELVN N/A
  • JBSS 7.40
  • 52 Week Low
  • ELVN $13.30
  • JBSS $58.47
  • 52 Week High
  • ELVN $30.03
  • JBSS $105.63
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 53.09
  • JBSS 61.05
  • Support Level
  • ELVN $19.38
  • JBSS $64.92
  • Resistance Level
  • ELVN $21.34
  • JBSS $67.05
  • Average True Range (ATR)
  • ELVN 1.16
  • JBSS 1.78
  • MACD
  • ELVN -0.17
  • JBSS 0.33
  • Stochastic Oscillator
  • ELVN 48.14
  • JBSS 92.15

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: